Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

On Oct. 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroup A, C, Y, and W-135) meningococcal conjugated vaccines (Menveo®, Novartis; and Menactra®, Sanofi Pasteur) for adolescents and persons with high risk for meningococcal disease.

ACIP 2010 Vaccine Updates: Meningococcal Conjugate Vaccines and Tdap